Concepedia

Patrick Altermatt

PA

Statistics

Publications

5

Citations

179

H-Index

5

Active since

2008

Affiliations

Vifor Pharma (Switzerland)(Current)

Vifor Pharma (United States)

Patrick Altermatt is an author at Vifor Pharma (Switzerland) specializing in ferroportin function, iron homeostasis regulation, and biochemistry.

Publications per year

2008–2023

5

Publications

5

Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia

Vania Manolova, Naja Nyffenegger, Anna Flace et al. · Journal of Clinical Investigation · 2019 · 90 citations · Full text

, , +17

Identification of the rapamycin‐sensitive phosphorylation sites within the Ser/Thr‐rich domain of the yeast Npr1 protein kinase

Stefan Gander, Débora Bonenfant, Patrick Altermatt et al. · Rapid Communications in Mass Spectrometry · 2008 · 31 citations

, , +12

Functional characterization of SLC39 family members ZIP5 and ZIP10 in overexpressing HEK293 cells reveals selective copper transport activity

Marcello Polesel, Álvaro Inglés‐Prieto, Eirini Christodoulaki et al. · BioMetals · 2022 · 29 citations · Full text

, , +15

Structures of ferroportin in complex with its specific inhibitor vamifeport

Elena Farah Lehmann, Márton Liziczai, Katarzyna Drożdżyk et al. · eLife · 2023 · 19 citations · Full text

, , +14

Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions

Natarajaswamy Kalleda, Anna Flace, Patrick Altermatt et al. · Haematologica · 2023 · 10 citations · Full text

, , +17

1–5 of 5